Skip to search.
 FTSE 100 Up 0.41%

Edwards Lifesciences Corp. (EW)

-NYSE
137.23 Up 1.76(1.30%) 19:58 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:135.47
Open:137.37
Bid:136.80 x 200
Ask:136.95 x 500
1y Target Est:171.40
Beta:0.467727
Earnings Date:21 Oct - 26 Oct (Est.)
Day's Range:135.73 - 137.81
52wk Range:96.84 - 159.00
Volume:677,134
Avg Vol (3m):1,098,320
Market Cap:14.75b
P/E (ttm):34.20
EPS (ttm):4.01
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for EW at this time.

Comparison

Symbol% ChgMkt Cap
EWUp 1.30%14.75b
ICUIUp 0.86%1.76b
STJUp 1.72%19.68b
MDTUp 1.96%100.25b

Key Statistics

Forward P/E (1 yr):28.70
P/S (ttm):5.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.37
Quarterly EPS Est (Sep-15) :0.98
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback